Agencies probe Merck for foreign anti-bribery law violations

NewsGuard 100/100 Score
Aug 11 2010
Merck, the second biggest international drug maker, is being investigated by two U.S. federal agencies for potentially breaking anti-bribery laws in foreign countries, The Associated Press reports. The Department of Justice and the Securities and Exchange Commission are both seeking information about Merck activities that may violate the Foreign Corrupt Practices Act, which, among other things, prohibits U.S.-based companies from bribing officials in other countries. Merck says it "has in place an FCPA compliance program, and our policy is to conduct our business in accordance with all applicable laws" (Johnson, 8/10).

Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Posted in: Healthcare News

Comments (0)

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback